We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Tecan and Pion Expand Collaboration to Develop Automated Drug Screening Solutions
News

Tecan and Pion Expand Collaboration to Develop Automated Drug Screening Solutions

Tecan and Pion Expand Collaboration to Develop Automated Drug Screening Solutions
News

Tecan and Pion Expand Collaboration to Develop Automated Drug Screening Solutions

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tecan and Pion Expand Collaboration to Develop Automated Drug Screening Solutions"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Following the launch of the manual assay systems for permeability and solubility, Tecan AG and pION INC have developed automated solutions for drug permeability and solubility screening.

The new automated application provides scalability from an upgradeable, entry-level manual system, to a fully automated system with medium or high throughput, according to changing requirements.

pION’s Double-Sink™ parallel artificial membrane permeability assay (PAMPA), a compound-sparing technique that helps to identify the most promising leads well in advance of cell-based methods, has been integrated with Tecan’s Freedom EVO® platform and Infinite® M200 plate reader in the PAMPA Evolution™.

The system offers enhanced walkaway time and high throughput for fully automated processing of permeability assays, while automated miniaturized shake-flask solubility assays can be done with the similarly configured µSOL Evolution™.

The flexibility of the Freedom EVO workstation also allows the same instrument to perform both permeability and solubility assays in a combined set-up, as well as other ADME assays.

The advanced Quad4 Monochromators™ technology in the Infinite M200 provides sensitivity and an optional MultiChannel Arm™ 96 in the Freedom EVO platform increases throughput with sample transfers.
Advertisement